| Literature DB >> 35145715 |
Andrew E Jimenez1, James D Fox1, Kara Miecznikowski1, David R Maldonado1, Benjamin R Saks1, Hari K Ankem1, Payam W Sabetian1, Ajay C Lall1, Benjamin G Domb1.
Abstract
There is a paucity of literature investigating the effect of lumbopelvic mobility on patient-reported outcome scores (PROs) after primary hip arthroscopy. The purpose of this study was (i) to report minimum 1-year PROs in patients with limited lumbopelvic mobility (LM) who underwent primary hip arthroscopy for femoroacetabular impingement syndrome (FAIS) and (ii) to compare clinical results with a propensity-matched control group of patients with normal lumbopelvic mobility (NM). Data were reviewed for surgeries performed between November 2019 and March 2020. Patients were considered eligible if they received a primary hip arthroscopy for FAIS in the setting of LM (seated to standing change in sacral slope ≤ 10°). LM patients were propensity-matched to a control group of patients with normal lumbopelvic motion (seated to standing change in sacral slope > 10°) for comparison. A total of 17 LM and 34 propensity-matched NM patients were included in the study. LM patients showed significant improvement in all outcome measures and achieved the minimum clinically important difference (MCID) and patient acceptable symptomatic state (PASS) at high rates for modified Harris Hip Score (MCID: 94% and PASS: 82%) and International Hip Outcome Tool-12 (iHOT-12; MCID: 94% and iHOT-12: 76%). When LM patients were compared to a propensity-matched control group of NM patients, they demonstrated similar postoperative PROs and rates of achieving MCID/PASS. LM patients who undergo primary hip arthroscopy may expect favorable short-term PROs at minimum 1-year follow-up. These results were comparable to a control group of NM patients.Entities:
Year: 2021 PMID: 35145715 PMCID: PMC8825469 DOI: 10.1093/jhps/hnab056
Source DB: PubMed Journal: J Hip Preserv Surg ISSN: 2054-8397
Fig. 1.Sacral slope measurements (yellow lines) on standing (A) and seated (B) x-rays.
Patient characteristics and demographic factors
|
| |||
|---|---|---|---|
|
|
|
| |
| Number of hips | 17 | 34 | |
| Sex | 0.192 | ||
| Male | 3 (18) | 12 (35) | |
| Female | 14 (82) | 22 (65) | |
| Follow-up time, months | 12.54 ± 0.68 (12.00–14.40) | 12.25 ± 0.37 (12.00–13.19) | 0.167 |
| Age at surgery, years | 39.85 ± 17.22 (12.72–76.41) | 31.98 ± 13.82 (14.75–70.92) | 0.127 |
| BMI, kg/m2 | 25.50 ± 4.45 (20.44–33.89) | 25.63 ± 5.41 (18.79–38.07) | 0.976 |
Data reported as n (%) or mean ± standard deviation (range), unless otherwise indicated. Bold indicates statistical significance (P < 0.05).
Radiographic measurements
|
| |||
|---|---|---|---|
|
|
|
| |
| Sacral slope | |||
| Sitting | 30.62 ± 8.94 | 19.35 ± 9.70 |
|
| Standing | 36.25 ± 9.40 | 41.80 ± 11.54 | 0.093 |
| Delta | 5.64 ± 2.19 | 22.46 ± 9.58 |
|
| Proximal femoral angle | |||
| Sitting | 88.43 ± 2.82 | 88.84 ± 3.70 | 0.792 |
| Standing | 4.29 ± 2.19 | 6.34 ± 4.48 |
|
| Femoroacetabular flexion angle | 78.5 ± 5.84 | 60.05 ± 11.51 |
|
Data reported in degrees as mean ± standard deviation. Bold indicates statistical significance (P < 0.05).
Intraoperative findings
|
| |||
|---|---|---|---|
|
|
|
| |
| Seldes type (labral tear) | 0.684 | ||
| I | 7 (41) | 17 (50) | |
| II | 2 (12) | 2 (6) | |
| I and II | 8 (47) | 14 (41) | |
| ALAD | 0.898 | ||
| 0 | 0 | 1 (3) | |
| 1 | 9 (53) | 14 (41) | |
| 2 | 5 (29) | 11 (32) | |
| 3 | 1 (6) | 3 (9) | |
| 4 | 2 (12) | 5 (15) | |
| Outerbridge: acetabulum | 0.898 | ||
| 0 | 0 | 1 (3) | |
| 1 | 9 (53) | 14 (41) | |
| 2 | 5 (29) | 11 (32) | |
| 3 | 1 (6) | 3 (9) | |
| 4 | 2 (12) | 5 (15) | |
| Outerbridge: femoral head | 0.204 | ||
| 0 | 15 (88) | 33 (97) | |
| 1 | 0 | 0 | |
| 2 | 1 (6) | 0 | |
| 3 | 1 (6) | 0 | |
| 4 | 0 | 1 (3) | |
| Ligamentum teres tear percentile | 0.227 | ||
| 0 | 5 (29) | 16 (47) | |
| 1 | 5 (29) | 11 (32) | |
| 2 | 5 (29) | 5 (15) | |
| 3 | 2 (12) | 2 (6) | |
Values are presented as number of hips (n), unless otherwise stated. Bold indicates statistical significance (P < 0.05).
Surgical procedures
|
| |||
|---|---|---|---|
|
|
|
| |
| Labral treatment | 0.392 | ||
| Repair | 15 (88) | 30 (88) | |
| Selective debridement | 1 (6) | 0 | |
| Reconstruction | 1 (6) | 2 (6) | |
| Capsular treatment | 0.250 | ||
| Repair | 17 (100) | 29 (85) | |
| Unrepaired capsulotomy | 0 | 5 (15) | |
| Acetabuloplasty | 16 (94) | 33 (97) | 0.610 |
| Femoroplasty | 17 (100) | 33 (97) | 0.475 |
| Microfracture acetabulum | 0 | 3 (9) | 0.207 |
Data reported as n (%), unless otherwise indicated. Bold indicates statistical significance (P < 0.05).
Patient-reported outcomes after propensity score matching
|
| |||
|---|---|---|---|
|
|
|
| |
| mHHS | |||
| Preoperative | 58.00 ± 11.78 (40–83) | 62.39 ± 15.86 (34–100) | 0.318 |
| 1 year | 85.35 ± 16.76 (40–100) | 84.03 ± 16.49 (43–100) | 0.835 |
|
|
|
| |
| Delta | 27.35 ± 17.24 (−14–52) | 21.64 ± 15.85 (−22–46) | 0.244 |
| NAHS | |||
| Preoperative | 59.78 ± 12.63 (40–81.25) | 63.36 ± 14.53 (32.5–92.5) | 0.391 |
| 1 year | 87.06 ± 13.12 (52.5–100) | 85.15 ± 14.71 (45–100) | 0.744 |
|
|
|
| |
| Delta | 27.28 ± 13.33 (−7.5–47.5) | 21.79 ± 14.42 (−5–61.25) | 0.195 |
| VAS | |||
| Preoperative | 4.69 ± 3.24 (0–8.52) | 5.12 ± 2.19 (0–9.1) | 0.622 |
| 1 year | 1.91 ± 1.87 (0–5) | 2.09 ± 2.19 (0–7) | 0.961 |
|
|
|
| |
| Delta | −2.78 ± 3.04 (−8.41–3.39) | −3.04 ± 3.04 (−9.1–4.23) | 0.776 |
| iHOT-12 | |||
| Preoperative | 30.79 ± 16.12 (7.42–53.58) | 35.06 ± 14.45 (12.62–59.73) | 0.343 |
| 1 year | 74.46 ± 23.54 (17.45–100) | 74.50 ± 22.91 (17.31–100) | 0.929 |
|
|
|
| |
| Delta | 43.66 ± 24.83 (0.09–91.60) | 39.44 ± 23.05 (−4.84–81.44) | 0.550 |
Values are presented as mean ± standard deviation (range). Bold indicates statistical significance (P < 0.05).
Clinical outcome thresholds after propensity score matching
|
| |||
|---|---|---|---|
|
|
|
| |
| MCID | |||
| mHHS | 16 (94) | 29 (85) | 0.650 |
| NAHS | 16 (94) | 29 (85) | 0.650 |
| iHOT-12 | 16 (94) | 29 (85) | 0.650 |
| PASS | |||
| mHHS | 14 (82) | 27 (79) | >0.999 |
| iHOT-12 | 13 (76) | 24 (71) | 0.749 |
| MOIST | |||
| mHHS | 14 (82) | 20 (59) | 0.122 |
| NAHS | 14 (82) | 22 (65) | 0.328 |
| iHOT-12 | 10 (59) | 20 (59) | >0.999 |
| VAS | 9 (53) | 20 (59) | 0.689 |
Values are presented as n (%). Bold indicates statistical significance (P < 0.05). MOIST, maximum outcome improvement satisfaction threshold.